Advances in Cancer Immunotherapy - New Haven Virtual Event
Advances in Cancer Immunotherapy™
Wednesday, Oct. 28, 2020
3:00 p.m. EDT
Organizers:
Marianne Davies, DNP, AOCNP – Yale School of Nursing
Roy S. Herbst, MD, PhD – Yale Cancer Center
Mario Sznol, MD – Yale School of Medicine
ACI New Haven Program Registration
Registration for the live virtual New Haven program is now available. Registration will close at 3:00 p.m. EDT on October 28, 2020. You must be registered to attend the program.
Program Agenda
Oct. 28, 2020 Program
The program is hosted through Zoom Webinar.
2:45–3:00 p.m. | Welcome, Introduction, SITC Resources |
Session I: Cancer Immunotherapy | |
3:00–3:30 p.m. | Immunotherapy for the Treatment of Skin Cancers |
3:30–4:00 p.m. | Immunotherapy for the Treatment of Lung Cancer |
4:00–4:30 p.m. | Immunotherapy for the Treatment of Hematologic Malignancies |
| 4:30–5:00 p.m. | Immunotherapy for the Treatment of Genitourinary Malignancies Daniel P. Petrylak, MD – Yale Cancer Center |
| 5:00–5:15 p.m. | Break |
| 5:15–5:45 p.m. | Immunotherapy for the Treatment of Head and Neck Cancers Aarti Bhatia, MD, MPH – Yale School of Medicine |
| 5:45–6:15 p.m. | Immunotherapy for the Treatment of Additional Solid Tumors (Breast/MSI+) Michael Cecchini, MD – Yale New Haven Hospital (MSI+) Lajos Pusztai, MD – Yale Cancer Center (Breast Cancer) |
| Session II: Immunotherapy Challenges and Beyond | |
| 6:15–6:40 p.m. | Practical Barriers in Cancer Immunotherapy Treatment TBA |
| 6:40–6:55 p.m. | Break |
| 6:55–7:40 p.m. | Toxicity Management Mario Sznol, MD – Yale School of Medicine Marianne Davies, DNP, AOCNP – Yale School of Nursing |
| 7:40–8:25 p.m. | What's Next for Cancer Immunotherapy, and COVID-19 in Cancer Immunotherapy Roy S. Herbst, MD, PhD –Yale Cancer Center Mario Sznol, MD –Yale School of Medicine |
| 8:25–8:30 p.m. | Closing Remarks |
Program Purpose
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory educational programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, these programs will facilitate understanding of:
- The rationale for common approaches to immunotherapy
- The appropriate clinical management of common side effects of immunotherapy agents
- Implementing appropriate cancer immunotherapy treatments for skin, lung, genitourinary, head and neck, hematologic and/or additional solid tumor cancers in clinical practice
- Overcoming operational and financial barriers to integrating cancer immunotherapy into their practice setting
- Appropriate implementation of cancer care counsel in the clinical setting
Attendees will also have an opportunity for connecting with regional experts in the immunotherapy field at the live event, through four quarterly webinars, and indefinitely through a dedicated online community forum. These connections will serve as ongoing resources while clinical oncologists and other healthcare providers incorporate immunotherapy into practice.
Speakers
Contact
Host Organization
- Society for Immunotherapy of Cancer